Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A to Z Trial: Simvastatin and Enoxaparin in ACS
NCT00251576Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 1999
- Primary completion
- Mar 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of simvastatin in acute coronary syndrome (ACS) (2 arms), sponsored by Organon & Co. Primary endpoint: Composite of cardiovascular death, MI, readmission for ACS at 2 years. Started Nov 1999; status: completed.
02
Drugs
simvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00251576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251576.